Advertisement

Pharmacy World and Science

, Volume 25, Issue 5, pp 191–196 | Cite as

Patient sources of drug information and attitudes to their provision: a corticosteroid model

  • V.F. Trewin
  • G.B.A. Veitch†
Article

Abstract

Aim: To determine patients' preferred sources of drug information and their attitudes to how this is provided.Design: A quantitative evaluation via personal interviews using a formal questionnaire.Subject and settings: A group of 101 in‐patients in a chest ward at the Royal Devon & Exeter Healthcare NHS Trust.Outcome measures: Preferred sources for medication advice; personal involvement in own treatment; adequacy of consultation period; medication compliance; post discharge sources of drug information; recalled benefits and side effects of corticosteroids.Results: Preferred source of drug information was: doctor (35%), pharmacist (11%) and nurse 4%. Sixty percent of patients wanted to be involved in the choice of their medication, thirty‐nine percent leaving it totally to the doctor and one patient who wanted the final word in what was prescribed. Sufficient discussion time with GPs was reported by 66% of patients (12%, insufficient) and 53% with hospital doctors (19%, insufficient). Non‐compliance with medication was reported by 66% and compliance by 24%. Medication advice sources used when at home were; community pharmacists (22%), GPs/books & magazines/specialist societies (all 18%), nurses (10%) and others less than 8%. Benefits of corticosteroids recalled by patients were: 'improving breathing' (14), 'general improvement' (9) and 'improved mobility'/'greater appetite' (both 5) 'with little change' reported by 13. Knowledge of side effects was much more comprehensive with; oedema/weight gain (50), skin/hair problems (33), osteoporosis (33), bruising (12) and mood changes (10) most commonly featured in responses. Almost all patients confirmed they liked to be given printed information about their medication.Conclusion: Patients sought their medication advice from a variety of sources and armed with this almost two thirds of patients wished to exercise their rights to be involved with their treatment planning. Sufficient discussion time appeared to be available to about half of the interviewees though only a few understood the intended benefits of prescribed corticosteroids used as an example in this work. A much better knowledge of drug side effects might have partly explained the high level of declared non‐compliance. Although pharmacists featured as the preferred source of drug information for some patients, a much more detailed investigation is needed of patients' attitudes to the profession and to individuals' consultation and communication skills.

Corticosteroids Counselling Information In‐patients Pulmonology 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Noyce PR. The therapeutic partnership - pharmacy's contribution. Pharm J 1991; 247: 357–9.Google Scholar
  2. 2.
    Mottram DR, Ford JL, Markey B, Mitchelson K. Public perception of community pharmacy. Pharm J 1989; 243: R14-7.Google Scholar
  3. 3.
    Smith FJ, Salkind MR. Factors influencing the extent of a pharmacist's advisory role in Greater London. Pharm J 1990; 244: R4-7.Google Scholar
  4. 4.
    Hargie O, Morrow N, Woodman C. Consumer perceptions of and attitudes to community pharmacy services. Pharm J 1992; 249: 668–91.Google Scholar
  5. 5.
    Williamson VK, Winn S, Livingstone CR, Pugh ALG. Public views on an extended role for community pharmacy. Int J Pharm Pract 1992; 1: 223–9.Google Scholar
  6. 6.
    McElnay JC, Nicholl AJ, Grainger-Rousseau TJ. The role of the community pharmacist - a survey of public opinion in Northern Ireland. Int J Pharm Pract 1993; 2: 95–100.Google Scholar
  7. 7.
    Tully MP, Hassell K, Noyce PR. Advice-giving in community pharmacies in the UK. J Health Serv Res Policy 1997; 2(1): 38–50.Google Scholar
  8. 8.
    Evans SW, John DN, Bloor JM, Luscombe DK. Utilisation of the advice offered by community pharmacists to clients presenting with symptoms. Pharm J 1995; 255: R29.Google Scholar
  9. 9.
    Donaghy D. The asthma specialist and patient education. Prof Nurse 1995; 11(3): 160–2.Google Scholar
  10. 10.
    Mulloy E, Donaghy D, Quigley C, McNicholas WT. A one-year prospective audit of an asthma education programme in an out-patient setting. Ir Med J 1996; 89(6): 226–8.Google Scholar
  11. 11.
    Levy ML. A randomized controlled evaluation of specialist nurse education following accident and emergency department attendance for acute asthma. Respir Med 2000; 94(9): 900–8.Google Scholar
  12. 12.
    Jones D, Seymour R, Woodhouse K. Use of pharmacists by older people in the community. Arch Geront Geriatr 1997; 24: 9–13.Google Scholar
  13. 13.
    Pilnick A. 'Why didn't you say just that?' Dealing with issues of asymmetry, knowledge and competence in the pharmacist/client encounter. Sociol Health Illness 1998; 20(1): 29–51.Google Scholar
  14. 14.
    Ried LD, Wang F, Young H, Awiphan R. Patients' satisfaction and their perception of the pharmacist. J Am Pharmaceut Assoc 1999; 39(6): 835–42.Google Scholar
  15. 15.
    Pharmacy in the future - implementing the NHS plan. London: The Department of Health, September 2000.Google Scholar
  16. 16.
    Pharmacists' engagement in continuing education and attitudes towards continuing professional development. Pharm J 20002; 269: 618–22.Google Scholar
  17. 17.
    Where the Society has got to now, and where it still has to go in the future. Pharm J 2002; 269: 445–6.Google Scholar
  18. 18.
    Evans SW, John DN, Bloor MJ, Luscombe DK. Use of non-prescription advice offered to the public by community pharmacists. Int J Pharm Pract 1997; 5: 16–25.Google Scholar
  19. 19.
    Ridout S, Waters WE, George CF. Knowledge of and attitudes to medicines in the Southampton community. Br J Clin Pharmacol 1986; 1: 701–12.Google Scholar
  20. 20.
    Ali A, Horne R. Patients want more information. Pharm Pract 1996; 6(9):333–8.Google Scholar
  21. 21.
    Allen KF, Sweeney SJ. The availability and design of patient information leaflets. Pharm J 1985; 235: 181–3.Google Scholar
  22. 22.
    Ley P, Llewellyn S. Improving patient understanding, recall, satisfaction and compliance. In: Broome A, Llewellyn S, editors. Health psychology: processes and applications. London: Chapman & Hall, 1995; 75–98.Google Scholar
  23. 23.
    Gibbs S, Waters WE, George CF. Prescription information leaflets: A national survey. J R Soc Med 1990; 83: 292–7.Google Scholar
  24. 24.
    Raynor DK, Knapp P. Do patients see, read and retain the new mandatory medicines information leaflets? Pharm J 2000; 264: 268–70.Google Scholar
  25. 25.
    Herxheimer A. Leaflets with NSAIDs do not warn users clearly - a UK survey. Pharm J 1999; 262: 559–61.Google Scholar
  26. 26.
    National Osteoporosis Society Report. New guidelines to help tackle corticosteroid-induced osteoporosis. Pharm J 1998; 261: 696.Google Scholar
  27. 27.
    Royal College of Physicians Report. New osteoporosis guidelines published. Pharm J 1999; 262: 389.Google Scholar
  28. 28.
    Marvel MK, Epstein RM, Flowers K, Beckman HB. Soliciting the patient's agenda. JAMA 1999; 281(3): 283–7.Google Scholar
  29. 29.
    Lang, F, McCord RS. Agenda setting in the patient-physician relationship. JAMA 1999; 282(10): 942–3 (Letter).Google Scholar
  30. 30.
    Levine MN, Gafni A, Markham B, Macfarlane D. A bedside decision instrument to elicit a patient's preference concerning adjuvant chemotherapy for breast cancer. Ann Intern Med 1992; 117: 53-8.Google Scholar
  31. 31.
    Fallowfield L. The ideal consultation. Br J Hosp Med 1992; 47(5): 364–7.Google Scholar
  32. 32.
    Turner-Warwick M. Patient/doctor relationship in the new NHS. Br J Hosp Med 1996; 56(1): 46–8.Google Scholar
  33. 33.
    Kaplan SH, Greenfield S, Gandek B, Rogers WH, Ware LE Jr. Characteristics of physicians with participatory decision-making styles. Ann Intern Med 1996; 124(5): 497–504.Google Scholar
  34. 34.
    Beckman HB, Frankel RM. The effect of physician behaviour on the collection of data. Ann Intern Med 1984; 101: 692–6.Google Scholar
  35. 35.
    Kaplan SH, Gandek B, Greenfield S, Rogers W, Ware JE. Patient and visit characteristics related to physicians' participatory decision-making style. Results from the Medical Outcome Study. Med Care 1995; 33(12): 1176–87.Google Scholar
  36. 36.
    O'Neil CK, Poirer TI. Impact of patient knowledge, patientpharmacist relationship, and drug perceptions on adverse drug therapy outcomes. Pharmacother 1998; 18(2):333–40.Google Scholar
  37. 37.
    Haw C, Stubbs J, Calton R, Haynes H. Antipsychotic medication. Hosp Pharmacist 2001; 8: 166–72.Google Scholar
  38. 38.
    NOS Conference Report. Osteoporotic hip fractures in men and women "could triple by the year 2040". Pharm J 1996; 256: 888.Google Scholar
  39. 39.
    Schneider DL, Barrett-Connor E, Morton DJ. Timing of postmenopausal estrogen for optimal bone density. JAMA 1997; 27: 543–7.Google Scholar
  40. 40.
    Peat ID, Healy S, Reid DM, Ralston SH. Steroid induced osteoporosis: an opportunity for prevention? Ann Rheum Dis 1995; 54: 66–8.Google Scholar
  41. 41.
    Walsh LJ, Wong CA, Pringle M, Tattersfield AE. Use of oral corticosteroids in the community and the prevention of secondary osteoporosis: a cross sectional study. BMJ 1996; 313: 344–6.Google Scholar
  42. 42.
    McCaig MDF, Bell FH, Bolger D, Davidson S. Prophylaxis against osteoporosis in a group of inpatients on oral corticosteroids. Pharm J 1999; 263: R18.Google Scholar

Copyright information

© Kluwer Academic Publishers 2003

Authors and Affiliations

  • V.F. Trewin
    • 1
  • G.B.A. Veitch†
    • 1
  1. 1.SPharmacy Department, Royal DevonExeter Healthcare NHS TrustExeterUK

Personalised recommendations